Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang(Pfizer (United States)), Junsuo Kan(University of Hong Kong), Siu Tsan Yuen(University of Hong Kong), Stephanie T. Shi(Pfizer (United States)), Kent‐Man Chu(University of Hong Kong), Simon Law(University of Hong Kong), Tsun Leung Chan(University of Hong Kong), Zhengyan Kan(Pfizer (United States)), Annie S.Y. Chan(Queen Mary Hospital), Wai Yin Tsui(Queen Mary Hospital), Siu Po Lee(University of Hong Kong), Siu Lun Ho(University of Hong Kong), Anthony K W Chan(University of Hong Kong), Grace H.W. Cheng(University of Hong Kong), Peter Roberts(Pfizer (United States)), Paul A. Rejto(Pfizer (United States)), Neil W. Gibson(Pfizer (United States)), David Pocalyko(Pfizer (United States)), Mao Mao(Pfizer (United States)), Jiangchun Xu(Pfizer (United States)), Suet Yi Leung(Queen Mary Hospital)
Cited by 773